Posts

How to Deliver Safe and Effective Adoptive Cell Therapy Products to Clinical Promise, Commercial Scale Manufacturing and Patients

LSX is an community of senior life science & healthcare decision-makers that develops connections with the capital and partners we need to grow our businesses.

The event brings together leaders from cancer research institutes, patient advocacy groups, early and late-stage investors, pharmas, & biotechs. 300+, 20+ company presentations, 50+% attendees are corporate and financial investors, analysts, bankers and advisors.

Your opportunity to connect with investors and strategic partners, Digital RESI June focuses on early-stage funding for all life science verticals: drugs, devices, diagnostics, digital health.

LSX is an community of senior life science & healthcare decision-makers that develops connections with the capital and partners we need to grow our businesses.

BioTrinity is an established, must-attend London conference, that catalyses growth and supports in-person re-engagement across the life sciences industry.

The event is attended by an audience of early stage and emerging life sciences R&D Companies, investors, big pharma, and other valued partners throughout the life sciences ecosystem. The conference features a focused, relevant, and stimulating programme, led by great speakers, who bring their knowledge, expertise, and vision to the fore in exciting, high-quality sessions.

The Longevity Leaders World Congress brings the world’s most prominent regenerative medicine and longevity scientists together, presenting the new research, responsible drug development, novel therapies and commercialisation to target age-related diseases.

Premier conference for ATMP community in Europe and beyond

Bio-Europe Spring is the most international biopharma industry gathering this spring. Delivered virtually, March 28-31, 2022, with over 2,700 assets posted, 60% biopharma attendance, 50+ countries expected to attend, and 1:1 meetings via the partneringONE® system.